GENETIC POLYMORPHISMS OF DRUG-METABOLIZING-ENZYMES AND LUNG-CANCER SUSCEPTIBILITY

被引:49
|
作者
KAWAJIRI, K
WATANABE, J
EGUCHI, H
HAYASHI, S
机构
[1] Department of Biochemistry, Saitama Cancer Center Research Institute, Saitama, 362, 818 Komuro, Ina
来源
PHARMACOGENETICS | 1995年 / 5卷
关键词
D O I
10.1097/00008571-199512001-00004
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
A close association of smoking-associated lung cancer incidence with the Msp I and Ile-Val polymorphisms of CYP1A1 gene was found in a Japanese population in terms of genotype frequency comparison and cigarette dose response. A synergistic increase in susceptibility to lung cancer was observed when the susceptible genotypes of CYP1A1 were combined with a deficient GSTM1 genotype. Individual difference in expression levels of Ahr and Arnt mRNAs was observed, and the expression levels of CYP1A1 appeared to associate with those of transcriptional factors, The Ahr protein has two different structures, ascribed to one amino acid replacement at codon 554 of Arg by Lys. However, this germ line polymorphism did not show a significant association with AHH inducibility nor lung cancer incidence, The p53 gene alterations in lung cancer tissues were more frequently observed among the patients with a susceptible allele of CYP1A1 gene.
引用
收藏
页码:S70 / S73
页数:4
相关论文
共 50 条
  • [41] IMPLICATION OF DRUG-METABOLIZING-ENZYMES IN DANTROLENE HEPATOTOXICITY
    JAYYOSI, Z
    STRAZIELLE, N
    LIVERTOUX, MH
    BATT, AM
    SIEST, G
    CYTOCHROME P-450 : BIOCHEMISTRY AND BIOPHYSICS /, 1989, : 747 - 750
  • [42] INDUCTION OF DRUG-METABOLIZING-ENZYMES - MECHANISMS AND CONSEQUENCES
    OKEY, AB
    ROBERTS, EA
    HARPER, PA
    DENISON, MS
    CLINICAL BIOCHEMISTRY, 1986, 19 (02) : 132 - 141
  • [43] IMMUNOMODULATING AGENTS AND HEPATIC DRUG-METABOLIZING-ENZYMES
    DESCOTES, J
    DRUG METABOLISM REVIEWS, 1985, 16 (1-2) : 175 - 184
  • [44] IMPLICATIONS FOR THERAPY OF DRUG-METABOLIZING-ENZYMES IN HUMAN-COLON CANCER
    MEKHAILISHAK, K
    HUDSON, N
    TSAO, MS
    BATIST, G
    CANCER RESEARCH, 1989, 49 (17) : 4866 - 4869
  • [45] EFFECT OF ENDOTOXIN ON THE EXPRESSION OF DRUG-METABOLIZING-ENZYMES
    WOLF, CR
    LINDSAY, RL
    ROGER, L
    ADAMS, DJ
    BRITISH JOURNAL OF CANCER, 1986, 54 (01) : 191 - 191
  • [46] ANALYSIS OF DRUG-METABOLIZING-ENZYMES WITH PH CURVE
    WADA, F
    SUZUKI, K
    ROKUHARA, M
    JAPANESE JOURNAL OF PHARMACOLOGY, 1976, 26 : P79 - P79
  • [47] MATURATIONAL DEVELOPMENT OF DRUG-METABOLIZING-ENZYMES IN SHEEP
    KAWALEK, JC
    ELSAID, KR
    AMERICAN JOURNAL OF VETERINARY RESEARCH, 1990, 51 (11) : 1736 - 1741
  • [48] CONTENTS OF DRUG-METABOLIZING-ENZYMES IN HEPATOCYTE CYTOPLASM
    WATANABE, J
    KANAMURA, S
    JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1990, 38 (07) : 1022 - 1022
  • [49] HEPATIC DRUG-METABOLIZING-ENZYMES IN UNDERNOURISHED MEN
    RAJPUROHIT, R
    KALAMEGHAM, R
    CHARY, AK
    KRISHNASWAMY, K
    TOXICOLOGY, 1985, 37 (3-4) : 259 - 266
  • [50] EFFECT OF TOLUIDINES ON DRUG-METABOLIZING-ENZYMES IN RAT-LIVER, KIDNEY AND LUNG
    GNOJKOWSKI, J
    BAERDUBOWSKA, W
    KLIMEK, D
    CHMIEL, J
    TOXICOLOGY, 1984, 32 (04) : 335 - 342